Cefaxone 250 mg (I.M) 1 Vial

Cefaxone is indicated for the treatment of infections caused by Pathogens sensitive to Ceftriaxone. Such infections include sepsis,meningitis in neonates and infants, abdominal infections (peritonitis, infections of the biliary tract), infections of the bones and joints, infections of soft tissues and skin, renal and urinary tract infections, respiratory tract infections particularly pneumonia, and uncomplicated gonorrhoea. It is also used for the treatment of ear, nose and throat infections. Cefaxone is also indicated as a perioperative prophylaxis of infections.

Dosage

Adults and children Over 12

1-2 vials of Cefaxone 1000 mg once daily. In severe infections and cases in which the pathogens are only moderately sensitive to Cefaxone, the daily dosage may be increased to 4 grams administered daily.

Infants and young children

May receive from 20-80 mg per kg body-mass/per day depending on the severity of the infection, usually every 12-24 hours. In cases of premature babies, the daily dosage should not exceed 50mg/kg body-mass on account of the immaturity of the infant’s enzyme systems.

Duration of therapy

The duration of therapy varies according to the disease. Administration of Cefaxone should be continued for a evidence of bacterial eradication has been obtained.